Simcere and Stanford Partner on Novel IPF Therapy Research
HONG KONG and STANFORD, Calif., June 12, 2026 Simcere Pharmaceutical Group Limited has entered into a strategic research collaboration...
Alzheimer’s Disease artificial intelligence ASCO 2026 Autoimmune Disease Bio-Pharma biologics biopharma Biotechnology Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Eli Lilly FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology oncology innovation Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine regulatory compliance targeted therapy
HONG KONG and STANFORD, Calif., June 12, 2026 Simcere Pharmaceutical Group Limited has entered into a strategic research collaboration...
BASEL, Switzerland, June 12, 2026 Novartis announced new Phase III data at the European Academy of Allergy and Clinical...
BOSTON and SHENZHEN, China, June 10, 2026 XtalPi, a global leader in AI and robotics-driven drug discovery, has announced...
WALTHAM, Mass., USA — April 2, 2026 Thermo Fisher Scientific Inc. has announced the global launch of the Gibco™...
San Francisco, CA – December 3, 2025 — Excelsior Sciences has raised $95 million in new funding to accelerate...
NEWTOWN, Pa., Nov. 25, 2025 — Catalyx, a global leader in machine vision, automation, and digital transformation for highly...
OTTAWA, November 5, 2025 — A new market report from Nova One Advisor, a subsidiary of Precedence Research, projects...
Lexington, Massachusetts – October 30, 2025 — Rapid Micro Biosystems, Inc. (Nasdaq: RPID), a leader in automated microbial quality...
CINCINNATI, OHIO, September 16, 2025 – Meridian Bioscience, Inc., a global leader in diagnostics and life science raw materials,...
